Search research articles
Contact Us
Filters
Showing results (71-80 of 189) with videos related to
Page
of 19
Sort By:
Journal of Hand Surgery (Edinburgh, Scotland)
|
August 1, 1992
Intercarpal arthrodesis by dowel bone grafting
M J Sandow, Y L Wai, M G Hayes
Acta Endocrinologica
|
August 1, 1987
An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months
H M Fraser, J Sandow, H Seidel, et al.
Fertility and Sterility
|
May 1, 1988
Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist
A Lemay, J Sandow, G Quesnel, et al.
Biochemical and Biophysical Research Communications
|
May 29, 1981
Degradation of luteinizing hormone - releasing hormone and analogs by adenohypophyseal peptidases
B Horsthemke, H Knisatschek, J Rivier, et al.
Pharmaceutical Research
|
November 1, 1988
The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats
S C Raehs, J Sandow, K Wirth, et al.
Geburtshilfe Und Frauenheilkunde
|
April 1, 1987
[Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin]
F Geisthövel, R Bliefert, H Geyer, et al.
International Journal of Peptide and Protein Research
|
July 1, 1996
S- and C-glycopeptide derivatives of an LH-RH agonist
K Michael, V Wittmann, W König, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1995
Pathways of degradation of buserelin by rat kidney membrane
U Kertscher, M Brudel, B Mehlis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer
J Waxman, J Sandow, H Thomas, et al.
Fertility and Sterility
|
June 1, 1989
Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography
J Donnez, B Schrurs, S Gillerot, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 189) with videos related to
Sort By:
Page
of 19
Journal of Hand Surgery (Edinburgh, Scotland)
|
August 1, 1992
Intercarpal arthrodesis by dowel bone grafting
M J Sandow, Y L Wai, M G Hayes
Acta Endocrinologica
|
August 1, 1987
An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months
H M Fraser, J Sandow, H Seidel, et al.
Fertility and Sterility
|
May 1, 1988
Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist
A Lemay, J Sandow, G Quesnel, et al.
Biochemical and Biophysical Research Communications
|
May 29, 1981
Degradation of luteinizing hormone - releasing hormone and analogs by adenohypophyseal peptidases
B Horsthemke, H Knisatschek, J Rivier, et al.
Pharmaceutical Research
|
November 1, 1988
The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats
S C Raehs, J Sandow, K Wirth, et al.
Geburtshilfe Und Frauenheilkunde
|
April 1, 1987
[Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin]
F Geisthövel, R Bliefert, H Geyer, et al.
International Journal of Peptide and Protein Research
|
July 1, 1996
S- and C-glycopeptide derivatives of an LH-RH agonist
K Michael, V Wittmann, W König, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1995
Pathways of degradation of buserelin by rat kidney membrane
U Kertscher, M Brudel, B Mehlis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer
J Waxman, J Sandow, H Thomas, et al.
Fertility and Sterility
|
June 1, 1989
Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography
J Donnez, B Schrurs, S Gillerot, et al.
Page
of 19